CEO Provides Update On The Progress Of Its Psilocybin Drug News Release (23-03-21): NeonMind (CSE: NEON) (OTC: NMDBF) CEO Provides Update On The Progress Of Its Psilocybin Drug Development Research Plan And Team. Read Here: https://neonmindbiosciences.com/neonmind-ceo-provides-update-on-the-progress-of-its-psilocybin-drug-development-research-plan-and-team/